Capital Performance Advisors’s Boston Scientific BSX Stock Holding History

Capital Performance Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,351	Closed	-$336K	–	335
2026 Q1	$336K	Buy	5,351 +2,538	+90%	+$203K	0.02%	299
2025 Q4	$268K	Buy	2,813 +297	+12%	+$29.1K	0.02%	344
2025 Q3	$246K	Buy	+2,516	New	+$261K	0.04%	269
2025 Q2	–	Sell	-2,291	Closed	-$231K	–	279
2025 Q1	$231K	Buy	+2,291	New	+$231K	0.05%	210
2024 Q4	–	Sell	-359	Closed	-$30.1K	–	540
2024 Q3	$30.1K	Buy	+359	New	+$28.3K	0.01%	483

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Performance Advisors's BSX Position: Q2 2026 in Review

Capital Performance Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,351 shares — an estimated $336K sold.

Capital Performance Advisors first reported a position in BSX in Q3 2024 and held it in 5 quarters. The position peaked at $336K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Capital Performance Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Capital Performance Advisors sold 5,351 Boston Scientific shares in Q2 2026, an estimated $336K.
Capital Performance Advisors first reported a position in Boston Scientific in Q3 2024 and held it in 5 quarters.
Capital Performance Advisors's Boston Scientific position peaked at $336K in Q1 2026.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.